Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diabetes Prevention Through Antiviral Treatment in Biobreeding Rats.
Niklasson B, Arbrandt G, Kawecki A, Juntti-Berggren L, Berggren PO, Al-Qahtani SM, Gustafsson AL, Bryzgalova G, Klitz W. Niklasson B, et al. Among authors: kawecki a. Viral Immunol. 2016 Oct;29(8):452-458. doi: 10.1089/vim.2016.0063. Epub 2016 Aug 9. Viral Immunol. 2016. PMID: 27505258
Association of zoonotic Ljungan virus with intrauterine fetal deaths.
Niklasson B, Samsioe A, Papadogiannakis N, Kawecki A, Hörnfeldt B, Saade GR, Klitz W. Niklasson B, et al. Among authors: kawecki a. Birth Defects Res A Clin Mol Teratol. 2007 Jun;79(6):488-93. doi: 10.1002/bdra.20359. Birth Defects Res A Clin Mol Teratol. 2007. PMID: 17335057 Clinical Trial.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
Narrow-band imaging vs Lugol chromoendoscopy in screening for esophageal squamous cell neoplasia: a randomized trial.
Chaber-Ciopinska A, Kiprian D, Wieszczy P, Bielasik A, Bugajski M, Januszewicz W, Jarzabski A, Niemiec M, Mroz A, Kawecki A, Regula J, Kaminski MF. Chaber-Ciopinska A, et al. Among authors: kawecki a. Pol Arch Intern Med. 2023 Oct 26;133(10):16462. doi: 10.20452/pamw.16462. Epub 2023 Mar 14. Pol Arch Intern Med. 2023. PMID: 36916462 Free article. Clinical Trial.
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651.
Haddad RI, Harrington K, Tahara M, Ferris RL, Gillison M, Fayette J, Daste A, Koralewski P, Zurawski B, Taberna M, Saba NF, Mak M, Kawecki A, Girotto G, Alvarez Avitia MA, Even C, Toledo JGR, Guminski A, Müller-Richter U, Kiyota N, Roberts M, Khan TA, Miller-Moslin K, Wei L, Argiris A. Haddad RI, et al. Among authors: kawecki a. J Clin Oncol. 2023 Apr 20;41(12):2166-2180. doi: 10.1200/JCO.22.00332. Epub 2022 Dec 6. J Clin Oncol. 2023. PMID: 36473143 Free PMC article. Clinical Trial.
Diagnosis and treatment of thyroid cancer in adult patients - Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych - Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022].
Jarząb B, Dedecjus M, Lewiński A, Adamczewski Z, Bakuła-Zalewska E, Bałdys-Waligórska A, Barczyński M, Biskup-Frużyńska M, Bobek-Billewicz B, Bossowski A, Buziak-Bereza M, Chmielik E, Czarniecka A, Czepczyński R, Ćwikła J, Dobruch-Sobczak K, Dzięcioł J, Gawlik A, Gawrychowski J, Handkiewicz-Junak D, Harasymczuk J, Hubalewska-Dydejczyk A, Januszkiewicz-Caulier J, Jarząb M, Kaczka K, Kalemba M, Kamiński G, Karbownik-Lewińska M, Kawecki A, Kluczewska-Gałka A, Kolasińska-Ćwikła A, Kołton M, Konturek A, Kos-Kudła B, Kotecka-Blicharz A, Kowalska A, Krajewska J, Kram A, Królicki L, Kukulska A, Kusiński M, Kuzdak K, Lange D, Ledwon A, Małecka-Tendera E, Mańkowski P, Migda B, Niedziela M, Oczko-Wojciechowska M, Polnik D, Pomorski L, Ruchała M, Samborski K, Skowrońska-Szcześniak A, Stanek-Widera A, Stobiecka E, Stojčev Z, Suchorzepka-Simek M, Syrenicz A, Szczepanek-Parulska E, Trofimiuk-Müldner M, Tysarowski A, Wygoda A, Zajkowska K, Zembala-Nożyńska E, Żyłka A. Jarząb B, et al. Among authors: kawecki a. Endokrynol Pol. 2022;73(2):173-300. doi: 10.5603/EP.a2022.0028. Endokrynol Pol. 2022. PMID: 35593680 Free article.
New Graphene Composites for Power Engineering.
Knych T, Mamala A, Kwaśniewski P, Kiesiewicz G, Smyrak B, Gniełczyk M, Kawecki A, Korzeń K, Sieja-Smaga E. Knych T, et al. Among authors: kawecki a. Materials (Basel). 2022 Jan 18;15(3):715. doi: 10.3390/ma15030715. Materials (Basel). 2022. PMID: 35160658 Free PMC article.
A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study.
Klinghammer K, Fayette J, Kawecki A, Dietz A, Schafhausen P, Folprecht G, Rottey S, Debourdeau P, Lavernia J, Jacobs A, Ahrens-Fath I, Dietrich B, Baumeister H, Zurlo A, Ochsenreither S, Keilholz U. Klinghammer K, et al. Among authors: kawecki a. ESMO Open. 2021 Oct;6(5):100242. doi: 10.1016/j.esmoop.2021.100242. Epub 2021 Sep 2. ESMO Open. 2021. PMID: 34482179 Free PMC article. Clinical Trial.
80 results